Abstract
Self-assembling peptides have very recently emerged as a new class of drug vehicles, as they hold unique advantages such as good biocompatibility, design flexibility, and controllable nanotructure. In this work, we report a self-assembling peptide containing D-amino acids (Nap- GDFDFDYGRGD) as the carrier of anticancer drug tetrandrine. Tetrandrine is a bis-benzylisoquinoline alkaloid isolated from the root of Hang-Fang-Chi (Stephania tetrandra S. Moore). The D-peptides were employed in this study as they have shown stronger resistance against proteases than their Lcounterpart with natural L-amino acids. The Nap-GDFDFDYGRGD peptides can self-assemble into nanofibers, which are able to efficiently encapsulate tetrandrine. The drug-loaded nanofibers are capable of sustained release of tetrandrine and being internalized by the LoVo cancer cells. The cytotoxicity studies indicate that the tetrandrine-loaded nanofibers possess similar cytotoxicity to free tetrandrine against LoVo cancer cells and the Nap- GDFDFDYGRGD nanofibers can be used as a safe vehicle.
Keywords: D-Amino acid, drug carrier, drug delivery, peptide, self-assembly, tetrandrine.
Graphical Abstract
Current Signal Transduction Therapy
Title:Self-assembling Peptide Nanofibers Containing D-amino Acids for Tetrandrine Delivery
Volume: 10 Issue: 2
Author(s): Qian Liu, Xiaoyong Yi and Xiaomeng Hu
Affiliation:
Keywords: D-Amino acid, drug carrier, drug delivery, peptide, self-assembly, tetrandrine.
Abstract: Self-assembling peptides have very recently emerged as a new class of drug vehicles, as they hold unique advantages such as good biocompatibility, design flexibility, and controllable nanotructure. In this work, we report a self-assembling peptide containing D-amino acids (Nap- GDFDFDYGRGD) as the carrier of anticancer drug tetrandrine. Tetrandrine is a bis-benzylisoquinoline alkaloid isolated from the root of Hang-Fang-Chi (Stephania tetrandra S. Moore). The D-peptides were employed in this study as they have shown stronger resistance against proteases than their Lcounterpart with natural L-amino acids. The Nap-GDFDFDYGRGD peptides can self-assemble into nanofibers, which are able to efficiently encapsulate tetrandrine. The drug-loaded nanofibers are capable of sustained release of tetrandrine and being internalized by the LoVo cancer cells. The cytotoxicity studies indicate that the tetrandrine-loaded nanofibers possess similar cytotoxicity to free tetrandrine against LoVo cancer cells and the Nap- GDFDFDYGRGD nanofibers can be used as a safe vehicle.
Export Options
About this article
Cite this article as:
Liu Qian, Yi Xiaoyong and Hu Xiaomeng, Self-assembling Peptide Nanofibers Containing D-amino Acids for Tetrandrine Delivery, Current Signal Transduction Therapy 2015; 10 (2) . https://dx.doi.org/10.2174/1574362410666150625190853
DOI https://dx.doi.org/10.2174/1574362410666150625190853 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Naphthyridines with Antiviral Activity - A Review
Medicinal Chemistry 3D QSAR Pharmacophore Modeling for c-Met Kinase Inhibitors
Medicinal Chemistry The Cancer Preventive Effects of Edible Mushrooms
Anti-Cancer Agents in Medicinal Chemistry Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
Current Drug Targets Time Recall; Future Concept of Chronomodulating Chemotherapy for Cancer
Current Pharmaceutical Biotechnology Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A
Anti-Cancer Agents in Medicinal Chemistry Antioxidant Effect of Mangiferin and its Potential to be a Cancer Chemoprevention Agent
Letters in Drug Design & Discovery Pharmacological Management of Type 2 Diabetes Mellitus: An Update
Current Diabetes Reviews Subject Index to Volume 3
Current Medicinal Chemistry - Central Nervous System Agents The Impact of Asymmetric Dimethylarginine (ADAMA), the Endogenous Nitric Oxide (NO) Synthase Inhibitor, to the Pathogenesis of Gastric Mucosal Damage
Current Pharmaceutical Design Targeting CSC-Related miRNAs for Cancer Therapy by Natural Agents
Current Drug Targets Chronotherapeutic Drug Delivery Systems - An Approach to Circadian Rhythms Diseases
Current Drug Delivery Targeting Opioid and Neurokinin-1 Receptors to Treat Alcoholism
Current Medicinal Chemistry The FKBP51-Glucocorticoid Receptor Balance in Stress-Related Mental Disorders
Current Molecular Pharmacology Recent Developments of Rebeccamycin Analogues as Topoisomerase I Inhibitors and Antitumor Agents.
Current Medicinal Chemistry The Role on Endoscopy in Alcohol-Related Diseases
Reviews on Recent Clinical Trials Herb-Drug Interactions: An Evidence Based Approach
Current Medicinal Chemistry Dietary Carbohydrates that Modulate the Immune System
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Molecular Components of Wnt/β-catenin Pathway As Therapeutic Targets For Upper Gastrointestinal Cancers
Clinical Cancer Drugs Cardiovascular and Renovascular Implications of COX-2 Inhibition
Current Pharmaceutical Design